Trial intelligence / Profile preview

Ivabradine for ventricular rate control in permanent atrial fibrillation with heart failure

TCTR20160706002Phase 4Completed

Sponsor
Faculty of Medicine Endowment Fund for Medical Research, Chiang Mai University
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in Atrial fibrillation (AFib), heart failure (HF), sponsored by Faculty of Medicine Endowment Fund for Medical Research, Chiang Mai University. Started Feb 2015; status: completed.

02

Drugs

ivabradine
03

Conditions

Atrial fibrillation (AFib)heart failure (HF)

Beyond the preview

Go deeper on TCTR20160706002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160706002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call